Assertio Holdings (ASRT) announced that Mark Reisenauer has been appointed as an independent director to the Company’s Board of Directors. Mr. Reisenauer will serve as a member of the Compensation Committee. He previously served as President of U.S. Commercial at Astellas Pharmaceuticals.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASRT:
- Assertio Holdings announces results of Rolvedon injection study
- Assertio Holdings appoints Schwichtenberg as CTO, Pietrya as CCO
- Largest borrow rate increases among liquid names
- Assertio Holdings price target lowered to $2.15 from $2.75 at Alliance Global
- Assertio Therapeutics Reports Strong Q3 and Board Changes